Alpha-1 Antitrypsin (intravenous)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Alpha-1 Antitrypsin (intravenous), covering 2025-08-24 to 2025-08-24. Get the full timeline:
Most recent: Clinical Trial Update: Intravenous Alpha-1 Antitrypsin for Hospitalized Patients With COPD Exacerbations (AECOPD Study) [Phase 2]